Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA vaccines for cancer: Principles to practice
Pablo Guasp, Charlotte Reiche, Zachary Sethna, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1163-1184
Closed Access | Times Cited: 16

Showing 16 citing articles:

Clinical advances of mRNA vaccines for cancer immunotherapy
Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100562-100562
Closed Access | Times Cited: 4
Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors
Zhao Yao, Taiqing Liu, Jingwen Wang, et al.
Biotechnology Advances (2025) Vol. 81, pp. 108546-108546
Closed Access | Times Cited: 1
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 4
Potential and development of cellular vesicle vaccines in cancer immunotherapy
Wenxi Zhao, Xianjun Li, Jialu Guan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
A Universal Therapeutic Vaccine Leveraging Autologous Pre‐Existing Immunity to Eliminate in Situ Uniformly Engineered Heterogeneous Tumor Cells
Fuhua Wu, Zhaofei Guo, Jialiang Yang, et al.
Advanced Materials (2025)
Closed Access
Advances in Vaccine-Based Therapies for Pancreatic Cancer
Matthew T. McMillan, Kevin C. Soares
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer

Nature (2025)
Closed Access
Advances in Polymer‐Based Self‐Adjuvanted Nanovaccines
Xiaoli Ling, Ziyan Dong, Jiao He, et al.
Small (2025)
Closed Access
Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy
Krishnendu Adhikary, Abhik Paul, А. К. Мадан, et al.
Advances in immunology (2025)
Closed Access
Fluorinated Ribonucleocarbohydrate Nanoparticles Allow Ultraefficient mRNA Delivery and Protein Expression in Tumor-Associated Myeloid Cells
Hyung Shik Kim, Grant G. Simpson, Fan Fei, et al.
Journal of the American Chemical Society (2025)
Open Access
Advocating for change—Integration of efforts across the drug discovery and development continuum
Timothy P. Heffernan, Giulio Draetta
Cancer Cell (2025)
Closed Access
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models
Romain Désert, Fabio Gianonne, Antonio Saviano, et al.
npj gut and liver. (2025) Vol. 2, Iss. 1
Open Access
Smart nanoparticle delivery of cancer vaccines enhances tumor immune responses: a review
Jihua Qiu, Chenghu Wu
Frontiers in Nanotechnology (2025) Vol. 7
Open Access
Personalized nanovaccines for treating solid cancer metastases
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection
Adam W. Smith, Isadora Zhang, Phong Trang, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1196-1196
Open Access | Times Cited: 1
Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC
A. Domínguez, M Perz, Yi Xu, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3564-3564
Open Access | Times Cited: 1
Page 1

Scroll to top